There are reasons for bizarre regulatory decisions in antiviral...

There are reasons for bizarre regulatory decisions in antiviral nasal sprays and it centres on profiteering of big pharma as uncontrolled oligopolies - most notably Pfizer. Big pharma provides 96% of TGA funding. Big pharma dominate director positions on the big lobbyist Medicines Australia which is third largest political donor after Clive Palmers Co at $244k in 2023. And big pharma got fast track to temporary approval of Paxlovid Lagevrio whilst full slow process was applied to other safer cheaper antivirals.

Firebrick even has TGA marketing approval from TGA registered but look it up and it is export only not Australia. Viraleze by Astodrimer sodium SPL copped a TGA fine and ban one week before 2021 Tokyo Olympics when Aussie swimmers used it so zero publicity in Australia.

BUT these safe protective AUSTRALIAN nasal sprays were stopped from Australian sales by our regulator.
That is why the shares in dropped from 2021

Shareholders need to await rationality but the big potential returns that should ethically have been available are going to be less likely. FRE is making bold moves to gain world market and there lies hope for shareholders of a bright Tunnel and no government muck ups of the next pandemic